Shingrix, The Shingles Vaccine, Could Reduce Your Risk Of Dementia
The new recombinant shingles vaccine, ‘Shingrix,’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study.
Shingrix (herpes zoster vaccine (recombinant, adjuvanted)). (Credit: Whispyhistory / CC BY-SA 4.0)
Evidence from a team of scientists at the University of Oxford indicates that the newer shingles vaccine is more protective against dementia compared to the previous shingles vaccine. Both shingles vaccines were associated with a lowered risk of dementia when compared to either the influenza vaccine or the tetanus / diphtheria / pertussis (Tdap) vaccine.
Keep reading with a 7-day free trial
Subscribe to Words About Birds to keep reading this post and get 7 days of free access to the full post archives.